| 2025-10-24 |
详情>>
股本变动：
变动后总股本13851.96万股
|
| 2025-10-24 |
详情>>
业绩披露：
2025年三季报(累计)每股收益2.99美元,归母净利润3.99亿美元,同比去年增长189.46%
|
| 2025-10-23 |
财报披露：
美东时间 2025-10-23 盘后发布财报
|
| 2025-07-24 |
详情>>
业绩披露：
2025年中报每股收益2.02美元,归母净利润2.69亿美元,同比去年增长589.09%
|
| 2025-06-01 |
详情>>
内部人交易：
Brooks Susan W股份增加5894.00股
|
| 2025-04-24 |
详情>>
业绩披露：
2025年一季报每股收益-0.1美元,归母净利润-1300万美元,同比去年增长68.29%
|
| 2025-04-03 |
股东大会：
将于2025-05-13召开股东大会
会议内容 ▼▲
- 1.To elect fourteen directors, each to serve for a term of one year to expire at the 2026 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as previously amended and restated (the “2009 Plan”), which was approved by our Board of Directors on March 12, 2025, subject to stockholder approval at the Annual Meeting;
4.To approve an amendment to the Restated Certificate of Incorporation of Community Health Systems, Inc. to permit the exculpation of officers;
5.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
6.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2025-02-19 |
详情>>
业绩披露：
2024年年报每股收益-3.9美元,归母净利润-5.16亿美元,同比去年增长-287.97%
|
| 2025-02-19 |
详情>>
业绩披露：
2022年年报每股收益0.35美元,归母净利润4600.00万美元,同比去年增长-80%
|
| 2024-10-24 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-3.38美元,归母净利润-4.46亿美元,同比去年增长-147.78%
|
| 2024-07-25 |
详情>>
业绩披露：
2024年中报每股收益-0.42美元,归母净利润-5500万美元,同比去年增长38.20%
|
| 2024-07-25 |
详情>>
业绩披露：
2023年中报每股收益-0.68美元,归母净利润-8900万美元,同比去年增长72.78%
|
| 2024-04-25 |
详情>>
业绩披露：
2024年一季报每股收益-0.32美元,归母净利润-4100万美元,同比去年增长19.61%
|
| 2024-03-28 |
股东大会：
将于2024-05-07召开股东大会
会议内容 ▼▲
- 1.To elect fourteen (14) directors, each to serve for a term of one year to expire at the 2025 Annual Meeting of Stockholders.
2.To hold an advisory vote on executive compensation.
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
4.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2024-02-21 |
详情>>
业绩披露：
2023年年报每股收益-1.02美元,归母净利润-1.33亿美元,同比去年增长-389.13%
|
| 2023-10-26 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-1.38美元,归母净利润-1.8亿美元,同比去年增长51.22%
|
| 2023-03-30 |
股东大会：
将于2023-05-09召开股东大会
会议内容 ▼▲
- 1.To elect twelve (12) directors, each to serve for a term of one year to expire at the 2024 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To hold an advisory vote on the frequency with which stockholders are provided an advisory vote on executive compensation;
4.To approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as previously amended and restated (the “2009 Plan”), which was approved by our Board of Directors on March 22, 2023, subject to stockholder approval at the Annual Meeting;
5.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
6.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2022-07-28 |
复牌提示：
2022-07-28 09:38:06 停牌，复牌日期 2022-07-28 09:43:22
|
| 2022-03-31 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.To elect twelve (12) directors, each to serve for a term of one year to expire at the 2023 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
4.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-01 |
股东大会：
将于2021-05-11召开股东大会
会议内容 ▼▲
- 1.To elect eleven (11) directors, each to serve for a term of one year to expire at the 2022 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as previously amended and restated (the “2009 Plan”), which was approved by our Board of Directors on March 17, 2021, subject to stockholder approval at the Meeting;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
5.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2020-04-02 |
股东大会：
将于2020-05-12召开股东大会
会议内容 ▼▲
- 1.To elect eleven (11) directors, each to serve for a term of one year to expire at the 2021 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as previously amended and restated (the “2009 Plan”), which was approved by our Board of Directors on March 20, 2020, subject to stockholder approval at the Meeting;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
5.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2019-04-04 |
股东大会：
将于2019-05-14召开股东大会
会议内容 ▼▲
- 1.To elect eleven (11) directors, each to serve for a term of one year to expire at the 2020 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
4.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2018-04-05 |
股东大会：
将于2018-05-15召开股东大会
会议内容 ▼▲
- 1.To elect ten (10) directors, each to serve for a term of one year to expire at the 2019 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, as previously amended and restated (the “2009 Plan”), which was approved by our Board of Directors on March 14, 2018, subject to stockholder approval at the Meeting;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
5.To consider a stockholder proposal described in the accompanying proxy statement if the stockholder proposal is properly presented for consideration at the Annual Meeting;
6.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2017-04-06 |
股东大会：
将于2017-05-16召开股东大会
会议内容 ▼▲
- 1.To elect eight (8) directors, each to serve for a term of one year to expire at the 2018 Annual Meeting of Stockholders;
2.To hold an advisory vote on executive compensation;
3.To hold an advisory vote on the frequency with which stockholders are provided an advisory vote on the compensation of our Named Executive Officers;
4.To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
5.To consider a stockholder proposal described in the accompanying proxy statement if the stockholder proposal is properly presented for consideration at the Annual Meeting;
6.To transact such other business as may properly come before the meeting and any adjournment or postponement thereof.
|
| 2016-04-07 |
股东大会：
将于2016-05-17召开股东大会
会议内容 ▼▲
- 1.Election of Directors
2.Proposal to approve the compensation of the Company’s named executive officers.
3.Proposal to approve the amendment and restatement of the Community Health Systems, Inc. 2009 Stock Option and Award Plan, which was approved by the Board of Directors as of March 16, 2016, subject to stockholder approval.
4.Proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016.
5.Stockholder proposal regarding proxy access.
|
| 2012-12-07 |
除权日：
美东时间 2012-12-13 每股派息0.25美元
|